Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, January 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Medication burden in patients with dialysis-dependent CKD: a systematic review

Article in Renal Failure (June 2024)

Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis

Article in American Journal of Nephrology (December 2023)

Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure

Article in Expert Opinion on Pharmacotherapy (August 2023)